1 asset in Alpha-Methylacyl-CoA Racemase Deficiency

Therapeutic assets addressing Alpha-Methylacyl-CoA Racemase Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Alpha-Methylacyl-CoA Racemase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)